Insider Trading History of Klencke Barbara

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Klencke Barbara since 2019. This trader's CIK number is 1647647. At the time of last reporting, Klencke Barbara was the Officer of Tscan Therapeutics, Inc.. (stock ticker symbol TCRX). Also see all insider trading activities at Tscan Therapeutics, Inc..

Note that in the past Klencke Barbara also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Sierra Oncology, Inc. (SRRA) by Klencke Barbara

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 SRRA 9,275 $113,488 0 $0 0 $0
2019 SRRA 229,000 $100,773 0 $0 0 $0

Yearly summary of insider trading at Tscan Therapeutics, Inc. (TCRX) by Klencke Barbara

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 TCRX 15,000 $82,550 0 $0 0 $0
2023 TCRX 5,000 $25,400 0 $0 0 $0


Insider trading activities at 2 companies by Klencke Barbara:

1. Sierra Oncology, Inc. (SRRA)

2. Tscan Therapeutics, Inc. (TCRX)

Table 1. Insider trading of Sierra Oncology, Inc. (SRRA) by Klencke Barbara

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-08-18 SRRA Buy 9,275 12.24 113,488
2019-08-23 SRRA Buy 108,000 .44 47,412
2019-08-22 SRRA Buy 121,000 .44 53,361

Table 2. Insider trading of Tscan Therapeutics, Inc. (TCRX) by Klencke Barbara

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-09-23 TCRX Buy 5,000 5.29 26,450
2024-08-26 TCRX Buy 5,000 5.53 27,650
2024-08-23 TCRX Buy 5,000 5.69 28,450
2023-12-14 TCRX Buy 5,000 5.08 25,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klencke Barbara (Officer of Tscan Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.